Innovative Pharma LLC is a venture capital fund based in Staten Island, New York. According to its most recent Form D, filed Dec 8, 2025, it has sold $5,130,750 of interests to 33 investors since its first sale in Nov 2025. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include Mukesh Prasad; Lawrence Jacobs.
- Total raised
- $5,130,750Cumulative sales reported on Form D
- Investors
- 33
- First sale
- Nov 26, 2025
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Mukesh Prasad; Lawrence Jacobs
- Latest Form D
- Dec 8, 2025
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Innovative Pharma LLC
What is the minimum investment for Innovative Pharma LLC?
Innovative Pharma LLC's latest Form D, filed Dec 8, 2025, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Innovative Pharma LLC?
Innovative Pharma LLC is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has Innovative Pharma LLC raised?
Innovative Pharma LLC reports $5,130,750 sold from 33 investors on its Form D filed Dec 8, 2025. This is cumulative sales since the offering began, not current assets or performance.
Where is Innovative Pharma LLC based?
Innovative Pharma LLC is based in Staten Island, New York.
When did Innovative Pharma LLC launch?
Innovative Pharma LLC reports its first sale in Nov 2025, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).
Size compared with every venture capital fund
Raised more than 69% of the 1,252 venture capital funds based in New York, and more than 82% of all 15,160 that report sales.